Bulletin Updates
Evonik and Ethris join forces on RNA delivery – 9 Sep 2025
Sep 09, 2025
The two companies will co-develop a lipid nanoparticle platform
Ethris contributes its SNaP LNP® technology
Evonik adds clinical manufacturing and process expertise
The goal is more stable, targeted nucleic acid therapies
The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »
Log in Start a free trial »